-
Feb 24, 2026, 10:36 am90 ptsNovo Nordisk announced Tuesday it will be slashing the list price of its blockbuster GLP-1 medications, Ozempic, Wegovy and Rybelsus, by up to 50 percent beginning next year. Starting on Jan. 1, 2027, the list price for Wegovy, Ozempic and Rybelsus, Novo's semaglutide products, will be $675 across…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.








